Takeda Pharmaceutical (TAK) Current Taxes (2018 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Current Taxes of $739.9 million for Q2 2026, down 29.08% year-over-year from $1.0 billion in Q2 2025, and up 18.55% quarter-over-quarter from $624.1 million in Q1 2026.
Takeda Pharmaceutical (TAK) Current Taxes (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's Current Taxes history runs 9 years deep, the most recent figure standing at $739.9 million for Q2 2026.
- In Q2 2026, Current Taxes fell 29.08% year-over-year to $739.9 million; the TTM figure through Jun 2026 stood at $739.9 million (down 29.08% YoY), while the FY2026 annual figure was $650.2 million, down 25.81% from the prior year.
- Current Taxes for Q2 2026 stood at $739.9 million, up from $624.1 million in the prior quarter.
- The five-year high for Current Taxes was $1.9 billion in Q2 2022, with the low at $624.1 million in Q1 2026.
- The 5-year median for Current Taxes is $1.0 billion (2025), against an average of $1.1 billion.
- Peak annual rise in Current Taxes reached 37.88% in 2024, while the deepest fall reached 57.78% in 2024.
- Takeda Pharmaceutical's Current Taxes stood at $1.3 billion in 2022, then sank by 43.07% to $760.7 million in 2023, then jumped by 37.88% to $1.0 billion in 2024, then decreased by 8.1% to $963.9 million in 2025, then decreased by 23.24% to $739.9 million in 2026.
- Business Quant data shows TAK's Current Taxes at $739.9 million in Q2 2026, $624.1 million in Q1 2026, and $963.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | -355.54 Mn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 138.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 739.89 Mn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 46.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 739.89 Mn |
| Mar 31, 2026 | 624.14 Mn |
| Dec 31, 2025 | 963.87 Mn |
| Sep 30, 2025 | 834.14 Mn |
| Jun 30, 2025 | 1.04 Bn |
| Mar 31, 2025 | 875.02 Mn |
| Dec 31, 2024 | 1.05 Bn |
| Sep 30, 2024 | 948.23 Mn |
| Jun 30, 2024 | 1.04 Bn |
| Mar 31, 2024 | 741.63 Mn |
| Dec 31, 2023 | 760.72 Mn |
| Sep 30, 2023 | 901.68 Mn |
| Jun 30, 2023 | 1.77 Bn |
| Mar 31, 2023 | 1.76 Bn |
| Dec 31, 2022 | 1.34 Bn |
| Sep 30, 2022 | 1.37 Bn |
| Jun 30, 2022 | 1.93 Bn |
| Mar 31, 2022 | 1.73 Bn |
| Dec 31, 2021 | 1.63 Bn |
| Sep 30, 2021 | 1.71 Bn |